Over 50% of Heart Attacks in Younger Women Aren't From Clogged Arteries

Key Takeaways

• Non-plaque causes account for >50% of heart attacks in women ≤65
• Supply‑demand oxygen mismatch drives 34% of female events
• Artery tears often misclassified, leading to ineffective plaque‑focused therapy
• Cellular iron overload worsens oxidative damage and heart‑failure risk
• Ferritin + TSAT testing identifies optimal iron range (50‑100 ng/mL, 25‑35% TSAT)

Pulse Analysis

The new JACC study overturns the long‑standing assumption that coronary plaque is the dominant trigger for myocardial infarction across all demographics. By meticulously reviewing imaging, lab data, and clinical records, researchers showed that atherosclerotic blockage explains only 47% of heart attacks in women under 65, compared with 75% in men. Instead, oxygen‑supply‑demand mismatch, spontaneous coronary artery dissection, and micro‑vascular spasm dominate the female profile, producing distinct mortality patterns—33% five‑year mortality for mismatch events versus under 10% for plaque‑related cases. This nuanced view forces a re‑evaluation of how clinicians categorize and code heart attacks, moving from a one‑size‑fits‑all model to cause‑specific pathways.

Parallel research into cardiac iron homeostasis adds another layer of complexity. While iron is essential for hemoglobin synthesis and mitochondrial energy production, excess intracellular iron catalyzes the formation of hydroxyl radicals, accelerating lipid peroxidation and DNA damage in cardiomyocytes. Experimental models demonstrate that reducing baseline iron stores before reperfusion curtails infarct size, suggesting that iron overload is a modifiable risk factor. The dual nature of iron—deficiency impairing oxygen transport, excess fueling oxidative stress—explains why standard serum ferritin alone can be misleading; pairing it with transferrin saturation (TSAT) offers a clearer picture of bioavailable iron.

For practitioners and health‑conscious consumers, these insights translate into actionable changes. Traditional risk calculators that prioritize LDL cholesterol and blood pressure may under‑detect women at risk for non‑plaque events, so incorporating assessments of anemia, inflammatory markers, and recent stressors becomes critical. Routine ferritin and TSAT panels can identify both iron deficiency and overload, guiding interventions ranging from targeted supplementation to therapeutic phlebotomy. Ultimately, a broader diagnostic lens—recognizing oxygen imbalance, arterial wall integrity, and iron balance—promises more personalized prevention, better allocation of therapies, and improved long‑term outcomes for younger women facing heart disease.